Glyburide
Average across 29 priced NDCs. A benchmark of pharmacy acquisition cost - not a retail quote.
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume - Medicaid only, not all-payer.
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Zydus Lifesciences Limited | generic | 18 | SUPPLYING |
| Teva Pharmaceuticals USA, Inc. | generic | 18 | SUPPLYING |
| Zydus Pharmaceuticals USA Inc. | generic | 18 | SUPPLYING |
| A-S Medication Solutions | repackager | 16 | SUPPLYING |
| Bryant Ranch Prepack | repackager | 15 | SUPPLYING |
| NuCare Pharmaceuticals,Inc. | repackager | 14 | SUPPLYING |
| Proficient Rx LP | repackager | 11 | SUPPLYING |
| Modavar Pharmaceuticals LLC | unknown | 8 | SUPPLYING |
| Preferred Pharmaceuticals Inc. | repackager | 8 | SUPPLYING |
| Cadila Pharmaceuticals Limited | unknown | 8 | SUPPLYING |
| Nivagen Pharmaceuticals, Inc. | unknown | 6 | SUPPLYING |
| Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | generic | 6 | SUPPLYING |
| Northwind Health Company, LLC | repackager | 4 | SUPPLYING |
| REMEDYREPACK INC. | repackager | 4 | SUPPLYING |
| Chartwell RX, LLC | generic | 3 | SUPPLYING |
+ 1 more labelers
Shortages, recalls, and registration changes attached to this drug concept.
Glyburide Tablet — reported in shortage by Sanofi-Aventis U.S. LLC. Therapeutic category: Endocrinology/Metabolism.
Glyburide Tablet — reported in shortage by Sanofi-Aventis U.S. LLC. Therapeutic category: Endocrinology/Metabolism.
